SCHEMBL31408461

SCHEMBL31408461

COc1ncc(-c2cc3[nH]c(CNC(C)=O)cc3cc2Cl)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ MTNR1A P48039 5/20 0.42
▸ MTNR1B P49286 4/20 0.42
▸ PTGES O14684 2/20 0.41
▸ ABL1 P00519 1/20 0.37
▸ AURKA O14965 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ EIF4E P06730 1/20 0.35
▸ ATP6AP1 Q15904 1/20 0.34
▸ PRKAG1 P54619 2/20 0.34
▸ PRKAA1 Q13131 2/20 0.34
▸ PRKAB1 Q9Y478 2/20 0.34
▸ CLK1 P49759 1/20 0.34
▸ CLK2 P49760 1/20 0.34
▸ CLK3 P49761 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ DYRK1B Q9Y463 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31408351 0.88 SMN1; SMN2 (0.40) SMN1; SMN2MTNR1AMTNR1BAURKAAURKB
SCHEMBL31408354 0.88 PRKAG1 (0.48) SMN1; SMN2MTNR1AMTNR1BPTGESAURKA
SCHEMBL31408333 0.85 SMN1; SMN2 (0.40) SMN1; SMN2MTNR1AMTNR1BMAPTMAPK1
SCHEMBL31408629 0.83 PTGES (0.42) SMN1; SMN2MTNR1AMTNR1BPTGESDYRK1A
SCHEMBL31408618 0.83 MTNR1A (0.43) SMN1; SMN2MTNR1AMTNR1BPTGESAURKA
SCHEMBL31408595 0.83 SMN1; SMN2 (0.44) SMN1; SMN2MTNR1AMTNR1BAURKAAURKB
SCHEMBL31408611 0.83 SMN1; SMN2 (0.41) SMN1; SMN2MTNR1AMTNR1BPRKAG1PRKAA1
SCHEMBL31408619 0.83 MTNR1A (0.44) SMN1; SMN2MTNR1AMTNR1BPTGESAURKA
SCHEMBL31408586 0.82 SMN1; SMN2 (0.40) SMN1; SMN2MTNR1AMTNR1BABL1AURKA
SCHEMBL31408594 0.82 SMN1; SMN2 (0.38) SMN1; SMN2MTNR1AMTNR1BAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback